Neogen Corporation

NEOG Healthcare Medical Devices

Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.

Revenue
+6.50%
EPS
−129.4%
Free cash flow
+135.6%
Total debt
−2.31%

Quarter to August 2026, against a year earlier

11.77 0.09 +0.77%
Market cap
$2.6B
P/E
0.0×
Fwd P/E
−93.3×
Dividend yield
—
F-score
5/9
Altman Z
1.11
Beneish M
−2.43
Dividend safety
n/a

Neogen Corporation (NEOG) Book value per share

Alert me on Book value per share

Neogen Corporation's book value per share at the end of fiscal 2026 was 9.6×, unchanged from fiscal 2025. At the end of the quarter to 31 August 2026 it was 9.6×. Over the past ten years it has ranged from 3.6× (fiscal 2015) to 16.6× (fiscal 2023); the current reading is higher than 83% of that period. Neogen Corporation ranks 36th of 149 Medical Devices companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2026 9.6× 0.77%
FY2025 9.5× (34.25%)
FY2024 14.5× (12.48%)
FY2023 16.6× 101.37%
FY2022 8.2× 4.43%
FY2021 7.9× 14.36%
FY2020 6.9× 12.25%
FY2019 6.1× 12.71%
FY2018 5.5× 16.86%
FY2017 4.7× 15.17%

Quarterly newest first

Period Book value per share Change
Aug 2026 9.6× (0.58%)
May 2026 9.6× (0.36%)
Feb 2026 9.7× (0.23%)
Nov 2025 9.7× (0.76%)
43 more quarters

Against its own ten years

Low 3.6× High 16.6×
Ten-year median 7.4×
Current reading's percentile 83

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on NEOG